Literature DB >> 15162527

Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma.

Xiang-Tao Ma1, Shan Wang, Ying-Jiang Ye, Ru-Yu Du, Zhi-Rong Cui, Ma Somsouk.   

Abstract

AIM: Signal transducers and activators of transcription (STATs) are a family of transcription factors activated in response to cytokines and growth factors. Constitutive activation of Stat3 has been observed in a growing number of tumor-derived cell lines, as well as tumor specimens from human cancers. The purpose of this study was to investigate the expression of p-Stat3, activated form of Stat3, and its downstream mediators including cyclin D1 and Bcl-x(L) in colorectal carcinoma (CRC), and to explore the possible mechanism of Stat3 signaling pathway in the tumorigenesis of colorectal carcinoma.
METHODS: Tissue samples from 45 patients of primary colorectal carcinoma were selected for studying Stat3 signaling pathway protein expression. Western blot analysis was used to measure the expression of p-Stat3, cyclin D1, and Bcl-x(L) proteins in colorectal carcinomas. Furthermore, the expression patterns of these proteins were analyzed for their distribution at the cellular level by immunohistochemical staining of the tissues.
RESULTS: Protein levels of p-Stat3, cyclin D1, and Bcl-x(L) were increased in colorectal carcinomas compared with adjacent normal mucosae (P<0.05). Elevated levels of p-Stat3 were correlated with the nodal metastasis and the stage (P<0.05). Overexpression of cyclin D1 was associated with the nodal metastasis (P<0.05). There was also a significant correlation between the expressions of p-Stat3 and cyclin D1 (r=0.382, P<0.05).
CONCLUSION: Constitutive activation of Stat3 may play an important role in the tumorigenesis of colorectal carcinoma, and the detailed mechanism of Stat3 signaling pathway in CRC deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162527      PMCID: PMC4572756          DOI: 10.3748/wjg.v10.i11.1569

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.

Authors:  Pedro J Real; Angels Sierra; Ana De Juan; Jose C Segovia; Jose M Lopez-Vega; Jose L Fernandez-Luna
Journal:  Oncogene       Date:  2002-10-31       Impact factor: 9.867

2.  Cancer incidence trends in urban shanghai, 1972-1994: an update.

Authors:  F Jin; S S Devesa; W H Chow; W Zheng; B T Ji; J F Fraumeni; Y T Gao
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

3.  Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.

Authors:  M Krajewska; S F Moss; S Krajewski; K Song; P R Holt; J C Reed
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

4.  Stat3 activation in prostatic carcinomas.

Authors:  Rajiv Dhir; Zuyao Ni; Wei Lou; Fernando DeMiguel; Jennifer Rubin Grandis; Allen C Gao
Journal:  Prostate       Date:  2002-06-01       Impact factor: 4.104

5.  Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

Authors:  Linda B Mora; Ralf Buettner; John Seigne; Jose Diaz; Nazeel Ahmad; Roy Garcia; Tammy Bowman; Robert Falcone; Rita Fairclough; Alan Cantor; Carlos Muro-Cacho; Sandy Livingston; James Karras; Julio Pow-Sang; Richard Jove
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

6.  Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance.

Authors:  D Y Feng; H Zheng; Y Tan; R X Cheng
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

7.  Cancer statistics, 2002.

Authors:  Ahmedin Jemal; Andrea Thomas; Taylor Murray; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

Review 8.  Control of myeloid differentiation and survival by Stats.

Authors:  T E Smithgall; S D Briggs; S Schreiner; E C Lerner; H Cheng; M B Wilson
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

9.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

Authors:  R Garcia; T L Bowman; G Niu; H Yu; S Minton; C A Muro-Cacho; C E Cox; R Falcone; R Fairclough; S Parsons; A Laudano; A Gazit; A Levitzki; A Kraker; R Jove
Journal:  Oncogene       Date:  2001-05-03       Impact factor: 9.867

10.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.

Authors:  R Catlett-Falcone; T H Landowski; M M Oshiro; J Turkson; A Levitzki; R Savino; G Ciliberto; L Moscinski; J L Fernández-Luna; G Nuñez; W S Dalton; R Jove
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

View more
  54 in total

1.  Inflammation and cancer.

Authors:  Noemí Eiró; Francisco J Vizoso
Journal:  World J Gastrointest Surg       Date:  2012-03-27

2.  ING4 enhances paclitaxel's effect on colorectal cancer growth in vitro and in vivo.

Authors:  Liyu Cao; Shunhua Chen; Cong Zhang; Cong Chen; Nana Lu; Yan Jiang; Yongping Cai; Yu Yin; Jianming Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 3.  Early-onset colorectal cancer: a sporadic or inherited disease?

Authors:  Vittoria Stigliano; Lupe Sanchez-Mete; Aline Martayan; Marcello Anti
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 4.  Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis.

Authors:  Shahab Uddin; Azhar R Hussain; Omar S Khan; Khawla S Al-Kuraya
Journal:  Tumour Biol       Date:  2013-09-07

5.  The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt.

Authors:  Olorunseun O Ogunwobi; Ian L P Beales
Journal:  Int J Colorectal Dis       Date:  2006-08-16       Impact factor: 2.571

6.  Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.

Authors:  T Kusaba; T Nakayama; K Yamazumi; Y Yakata; A Yoshizaki; T Nagayasu; I Sekine
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

Review 7.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  The role of STAT3 activation in modulating the immune microenvironment of GBM.

Authors:  Alfred P See; James E Han; Jillian Phallen; Zev Binder; Gary Gallia; Fan Pan; Dilini Jinasena; Christopher Jackson; Zineb Belcaid; Sung Jin Jeong; Chelsea Gottschalk; Jing Zeng; Jacob Ruzevick; Sarah Nicholas; Young Kim; Emilia Albesiano; Drew M Pardoll; Michael Lim
Journal:  J Neurooncol       Date:  2012-10-25       Impact factor: 4.130

9.  IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma.

Authors:  Jennifer Dien Bard; Pascal Gelebart; Mona Anand; Zoulika Zak; Samar A Hegazy; Hesham M Amin; Raymond Lai
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

10.  Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression.

Authors:  Jill J Ranger; David E Levy; Solmaz Shahalizadeh; Michael Hallett; William J Muller
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.